4-Bromo-1-chloro-2-(4-ethoxy-benzyl)-benzene (CAS No: 461432-23-5) is a key pharmaceutical intermediate used in the synthesis of APIs Dapagliflozin. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: 4-bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]benzene, 4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether
CAS No: 461432-23-5
PubChem CID: 9996449
Mol Formula: C15H14BrClO
Mol Weight: 325.63 g/mol
Used in API: Dapagliflozin
IUPAC Name: 4-bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]benzene
API Intermediate Description: 4-Bromo-1-chloro-2-(4-ethoxy-benzyl)-benzene is used as a key intermediate in the synthesis of pharmaceutical drugs, specifically the antidiabetic medications Dapagliflozin and Empagliflozin. These drugs are inhibitors of the sodium-glucose co-transporter type 2 (SGLT2) and are used to help manage blood glucose levels in people with type 2 diabetes. This compound is crucial for the development and production of these active pharmaceutical ingredients (APIs) in both research and large-scale manufacturing settings.
